Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07214389 · ClinicalTrials.gov registry record · NA
PRoducing Outcome Measures for OTP Quality Improvement
A NA study, sponsored by RTI International.
- Recruiting
- Registry status
- NA
- Development phase
- 4,500
- Enrollment target
NCT07214389: Recruiting NA study, sponsored by RTI International.
NCT07214389 is a NA study that is actively recruiting participants, run by RTI International. The registered enrollment target is 4,500 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (221% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07214389, a NA study, is actively recruiting participants, sponsored by RTI International.
- RECRUITING
- Registry status
- NA
- Development phase
- 4,500 participants
- Enrollment target
Study Summary
This study tests ways to help opioid treatment programs (OTPs) keep patients in care. Staying on methadone or buprenorphine is linked to better outcomes, yet many people leave treatment early. The project will compare two approaches that provide clinics with retention/outcome quality measures and a quality-improvement (QI) toolkit-either alone or with added facilitation-against usual care. Forty-five BayMark OTPs in multiple states will be randomly assigned to one of three groups: (1) quality measures + QI toolkit; (2) quality measures + QI toolkit + external QI facilitation; or (3) usual care. The primary outcome is 90-day retention in treatment, measured from OTP electronic health records and Medicaid claims. Secondary outcomes include emergency department visits, hospitalizations, overdoses, and mortality. Findings will identify practical, scalable strategies to improve patient retention in OTPs.
Primary Outcome
The primary endpoint in the quantitative analyses will be the OTP's 90-day treatment retention rate.
Interventions
- BEHAVIORAL Quality Measures (Audit and Feedback)
- BEHAVIORAL Quality Improvement (QI) Toolkit
- BEHAVIORAL External QI Facilitation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,500 participants |
| Start Date | 2025-10-03 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07214389 shows while recruiting
NCT07214389 is an interventional study that assigns participants to a tested intervention. Its 4,500 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (221% higher).
The record links to 0 conditions, and to 3 interventions - of which Quality Measures (Audit and Feedback) is the first listed.
NCT07214389 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07214389 about?
NCT07214389 is a clinical study titled "PRoducing Outcome Measures for OTP Quality Improvement". This study tests ways to help opioid treatment programs (OTPs) keep patients in care. Staying on methadone or buprenorphine is linked to better outcomes, yet many people leave treatment early. The project will compare two approaches that provide clinics with retention/outcome quality measures and a ...
What is the current status of trial NCT07214389?
This trial is currently recruiting. It is a NA study. The enrollment target is 4,500 participants. The study started on 2025-10-03. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07214389?
The interventions under investigation include: Quality Measures (Audit and Feedback) (BEHAVIORAL), Quality Improvement (QI) Toolkit (BEHAVIORAL), External QI Facilitation (BEHAVIORAL).
Who is sponsoring clinical trial NCT07214389?
This trial is sponsored by RTI International, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07214389's enrollment target sits among peer trials
4,500 29th of 2000 higher than 1,971 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06533111 · 4,500 participants · NA
Improving Surgical Patient Outcomes Through Implementation of a SemiStructured Intraoperative Anesthesia Handoff Tool
- NCT06588452 · 4,500 participants
Manual Versus AI-Assisted Clinical Trial Screening Using Large-Language Models
- NCT07165028 · 4,500 participants · Phase 3
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
- NCT07207564 · 4,500 participants
Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI